<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
<title>BRIDG Release 2.2 -- Static Classes::StudyProtocol</title>
<link href="../../../../css/ea.css" rel="stylesheet" type="text/css" />
<script>
function initPage(src) {
	if(parent==this&&(this.location+"").indexOf('EARoot')!=-1)
		document.location=(this.location+"").substring(0,(this.location+"").indexOf('EARoot'))+"index"+(this.location+"").substring((this.location+"").lastIndexOf('.'))+"?goto="+((this.location+"").substring((this.location+"").indexOf('EARoot')+7,(this.location+"").lastIndexOf('.')).replace(/\//g,':').replace(/EA/g,""));
	else
		parent.initPage(src);
}
</script>
</head>
<body onload="initPage(this);" class="Content">
<div class="pageHeader"></div>
<div class="PageBody">
	<span class="ObjectTitle">StudyProtocol  : public   class</span>
	<table border="0" cellpadding="0" cellspacing="0" class="ObjectDetails">
		<tr>
			<td width="15%" class="ObjectDetailsTopic">Created:</td>
			<td width="85%" class="ObjectDetailsValue">3/14/2005 4:52:38 PM</td>
		</tr>
		<tr>
			<td class="ObjectDetailsTopic">Modified:</td>
			<td class="ObjectDetailsValue">4/29/2009 3:45:28 PM</td>
		</tr>
		<tr style="height: 10px"><td colspan="2"></td></tr>
		<tr>
			<td class="ObjectDetailsTopic"><img src="../../../../images/plus03.gif" align="absmiddle" id="proj" onclick="parent.toggleData(this.id)" />Project:</td>
			<td class="ObjectDetailsValue"></td>
		</tr>
		<tr id="proj00" style="display: none;">
			<td class="ObjectDetailsTopic" style="padding-left: 18px;">Author:</td>
			<td class="ObjectDetailsValue"></td>
		</tr>
		<tr id="proj01" style="display: none;">
			<td class="ObjectDetailsTopic" style="padding-left: 18px;">Version:</td>
			<td class="ObjectDetailsValue"></td>
		</tr>
		<tr id="proj02" style="display: none;">
			<td class="ObjectDetailsTopic" style="padding-left: 18px;">Phase:</td>
			<td class="ObjectDetailsValue"></td>
		</tr>
		<tr id="proj03" style="display: none;">
			<td class="ObjectDetailsTopic" style="padding-left: 18px;">Status:</td>
			<td class="ObjectDetailsValue">Release 2.2</td>
		</tr>
		<tr id="proj04" style="display: none;">
			<td class="ObjectDetailsTopic" style="padding-left: 18px;">Complexity:</td>
			<td class="ObjectDetailsValue">Easy</td>
		</tr>
		<tr>
			<td class="ObjectDetailsTopic"><img src="../../../../images/plus03.gif" align="absmiddle" id="adv" onclick="parent.toggleData(this.id)" />Advanced:</td>
			<td class="ObjectDetailsValue"></td>
		</tr>
		<tr id="adv00" style="display: none;">
			<td class="ObjectDetailsTopic" style="padding-left: 18px;">UUID:</td>
			<td class="ObjectDetailsValue">{792E71ED-0AD4-4eaf-A499-8AFB57DB3E62}</td>
		</tr>
		<tr id="adv01" style="display: none;">
			<td class="ObjectDetailsTopic" style="padding-left: 18px;">Appears In:</td>
			<td class="ObjectDetailsValue"><a href="EA1542.htm">View 1 - Protocol-Driven Research</a>, <a href="EA1546.htm">View 3 - Document</a>, <a href="EA1552.htm">View 6 - Complete - Classes,  Attributes,  Inheritance</a>, <a href="EA1548.htm">View 4 - Adverse Event</a>, <a href="EA1544.htm">View 2 - Study Design</a>, <a href="EA1550.htm">View 5 - Protocol Representation</a></td>
		</tr>
	</table>
	<div class="ObjectDetailsNotes">&lt;p&gt;An action plan for a formal investigation to assess the utility, impact, pharmacological, physiological, and psychological effects of a particular treatment, procedure, drug, device, biologic, food product, cosmetic, care plan, or subject characteristic.&lt;br/&gt;&lt;/p&gt;&lt;p&gt;&lt;br/&gt;&lt;/p&gt;&lt;p&gt;Note: Among other things, the &lt;i&gt;action plan&lt;/i&gt; may include the design, statistical considerations and all activities to test a particular hypothesis that is the basis of the study.&#160; The study may be of any type that involves StudySubjects, including prevention, therapeutic, interventional or observational.&#160; Subjects may be biological entities (human, animal, specimen, tissue, organ, etc.) or products. &lt;br/&gt;&lt;/p&gt;&lt;p&gt;&lt;br/&gt;&lt;/p&gt;&lt;p&gt;NOTE: The StudyProtocol class encapsulates the semantics of two &#39;views&#39; of the single concept &#39;study.&#39;&#160; The name &#39;StudyProtocol&#39; was chosen to both disambiguate the somewhat overloaded term &#39;protocol,&#39; as well as to emphasize that the class has two important relationships to the Document class, each of which emphasizes a different aspect of the overall semantics of the StudyProtocol class:&lt;br/&gt;&lt;/p&gt;&lt;p&gt;1). StudyProtocol is a sub-class of the Document class:&lt;br/&gt;&lt;/p&gt;&lt;p&gt;StudyProtocol is a sub-class of Document and, as such, inherits all of the basic characteristics of its parent.&#160; In particular, an instance can contain all of the definitions, specifications, and content of the various (logical) documents which collectively define a study, including (but not limited to) documents that describe the objective(s), background, and/or plan (including the design, methodology, statistical considerations, organization, or other supplemental materials that describe the required information of a Study.&lt;br/&gt;&lt;/p&gt;&lt;p&gt;2). StudyProtocol is a collector for Document instances:&lt;br/&gt;&lt;/p&gt;&lt;p&gt;StudyProtocol is a collector for all various artifacts (including the protocol itself) which collectively define a study, including (but not limited to) specifications of planned, scheduled, or performed Activities, ObservationResults, Assessments, Analyses and their various inter-relationships.&lt;br/&gt;&lt;/p&gt;&lt;p&gt;&lt;br/&gt;&lt;/p&gt;&lt;p&gt;NOTE:&#160; A StudyProtocol can be either Primary or Correlative.&#160; A StudyProtocol is considered to be Primary if it has one or more Correlative studies associated with it.&#160; A Correlative study extends the objectives or observations/conclusions of a Primary study, enrolling the same (or a subset of the same) subjects as were enrolled in the Primary study. (Correlative Studies are not modeled in BRIDG yet.)&lt;br/&gt;&lt;/p&gt;&lt;p&gt;&lt;br/&gt;&lt;/p&gt;&lt;p&gt;NOTE: We are assuming that a document is a container, which may be physical or logical, with the six characteristics listed in the definition of the Document class.&#160; This class is the container for the Plan. &lt;br/&gt;&lt;/p&gt;&lt;p&gt;&lt;br/&gt;&lt;/p&gt;&lt;p&gt;NOTE: StudyProtocol describes the pre-study, study, and post-study portions of the plan. &lt;br/&gt;&lt;/p&gt;</div>

	<div class="TableGroup" id="TableGroup">
		<ul class="ItemTitle">
			<li onClick="parent.toggleItem('Attributes');" id="AttributesTitle">Attributes</li>
			<li onClick="parent.toggleItem('AssociationsTo');" id="AssociationsToTitle">Associations To</li>
			<li onClick="parent.toggleItem('AssociationsFrom');" id="AssociationsFromTitle">Associations From</li>
			<li onClick="parent.toggleItem('Links');" id="LinksTitle">Other Links</li>
		</ul>
<div class="ItemBody" id="AttributesTable">
	<table border="0" cellspacing="0" cellpadding="0" class="Table">
		<tr>
			<td width="40%" class="TableHeading">Attribute</td>
			<td width="60%" class="TableHeading">Details</td>
		</tr>
						<tr>
				<td width="40%" class="TableRow" valign="top"><i>public ST</i><br /><strong>&nbsp;&nbsp;acronym</strong></td>
				<td width="60%" class="TableRow" valign="top"><i></i>Map:CTGOV=Acronym<br>Map:WHO=Acronym<br><div class="ObjectDetailsNotes"><table>
	<tr>
		<td valign="top">
			<i>Notes: </i><span style="margin-left: .4cm;"> </span>
		</td>
		<td>
			The initials used to identify the study, if applicable.&nbsp;<WBR> &lt;br /&gt;&lt;br /&gt;For example, WHI for Women&#39;s Health Initiative
		</td>
	</tr>
</table></div>
</td>
			</tr>			<tr>
				<td width="40%" class="TableRow" valign="top"><i>public CD</i><br /><strong>&nbsp;&nbsp;phaseCode</strong></td>
				<td width="60%" class="TableRow" valign="top"><i></i>Map:CTGOV=Study Design Study Phase<br>Map:WHO=Study Type.Phase<br><div class="ObjectDetailsNotes"><table>
	<tr>
		<td valign="top">
			<i>Notes: </i><span style="margin-left: .4cm;"> </span>
		</td>
		<td>
			Coded designation of approval phase for a study protocol.&lt;font color=&quot;#ff0000&quot;&gt; &lt;/font&gt;&lt;br /&gt;&lt;br /&gt;For example, I, I/II, II, III, N/A.&lt;br /&gt;&lt;br /&gt;NOTE: Studies are generally categorized into four (sometimes five) phases described separately herein. An investigational medicine or product may be evaluated in two or more phases simultaneously in different studies, and some studies may overlap two different phases. Phase 1: The initial introduction of an investigational new drug into humans. Phase 1 studies are typically closely monitored and may be conducted in patients or normal volunteer subjects.&nbsp;<WBR> Phase 2: Controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in patients with the disease or condition under study and to determine the common short-term side effects and risks associated with the drug. Phase 3: Studies are expanded controlled and uncontrolled trials. They are performed after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather the additional information about effectiveness and safety that is needed to evaluate the overall benefit-risk relationship of the drug and to provide an adequate basis for physician labeling. Phase 3b: Phase 3b studies are a sub category of phase 3 trials near the time of approval to elicit additional findings. Phase 4:&nbsp;<WBR> Concurrent with marketing approval, Food and Drug Administration (FDA) may seek agreement from the sponsor to conduct certain post-marketing (phase 4) studies to delineate additional information about the drug&#39;s risks, benefits, and optimal use. Phase 5: Post-marketing surveillance is sometimes referred to as Phase 5. 
		</td>
	</tr>
</table></div>
</td>
			</tr>			<tr>
				<td width="40%" class="TableRow" valign="top"><i>public SET<CD></i><br /><strong>&nbsp;&nbsp;diseaseCode</strong></td>
				<td width="60%" class="TableRow" valign="top"><i></i>Map:CTGOV=Conditions or Focus of Study<br><div class="ObjectDetailsNotes"><table>
	<tr>
		<td valign="top">
			<i>Notes: </i><span style="margin-left: .4cm;"> </span>
		</td>
		<td>
			Code to represent the condition that is the focus of the study. &lt;br /&gt;&lt;br /&gt;For example, in a study to examine risk factors for Lupus, might have as an inclusion criterion &quot;healthy volunteer&quot;, but the target condition code would be a Lupus SNOMED code.
		</td>
	</tr>
</table></div>
</td>
			</tr>			<tr>
				<td width="40%" class="TableRow" valign="top"><i>public CD</i><br /><strong>&nbsp;&nbsp;targetAnatomicSiteCode</strong></td>
				<td width="60%" class="TableRow" valign="top"><i></i><div class="ObjectDetailsNotes"><table>
	<tr>
		<td valign="top">
			<i>Notes: </i><span style="margin-left: .4cm;"> </span>
		</td>
		<td>
			The anatomic site(s) on which the study is focused.&lt;br /&gt;&lt;br /&gt;For example, breast, ovary.
		</td>
	</tr>
</table></div>
</td>
			</tr>			<tr>
				<td width="40%" class="TableRow" valign="top"><i>public CD</i><br /><strong>&nbsp;&nbsp;primaryPurposeCode</strong></td>
				<td width="60%" class="TableRow" valign="top"><i></i>Map:CTGOV=Intervention Type<br>Map:CTGOV=Study Design Primary Purpose<br><div class="ObjectDetailsNotes"><table>
	<tr>
		<td valign="top">
			<i>Notes: </i><span style="margin-left: .4cm;"> </span>
		</td>
		<td>
			Code to identify a type of study protocol based upon the intent of the study&#39;s activities.&lt;br /&gt;&lt;br /&gt;For example, treatment studies test new treatments, new combinations of drugs, or new approaches to surgery or radiation therapy. Prevention studies look for better ways to prevent disease in people who have never had the disease or to prevent a disease from returning. These approaches may include medicines, vitamins, vaccines, minerals, or lifestyle changes. Diagnostic studies are conducted to find better tests or procedures for diagnosing a particular disease or condition. Screening studies test the best way to detect certain diseases or health conditions. Quality of Life studies (or Supportive Care trials) explore ways to improve comfort and the quality of life for individuals with a chronic illness.&nbsp;<WBR> 
		</td>
	</tr>
</table></div>
</td>
			</tr>			<tr>
				<td width="40%" class="TableRow" valign="top"><i>public ST</i><br /><strong>&nbsp;&nbsp;purposeStatement</strong></td>
				<td width="60%" class="TableRow" valign="top"><i></i><div class="ObjectDetailsNotes"><table>
	<tr>
		<td valign="top">
			<i>Notes: </i><span style="margin-left: .4cm;"> </span>
		</td>
		<td>
			A statement describing the overall rationale of the study.&nbsp;<WBR> This field describes the contribution of this study to product development, i.e., what knowledge is being contributed from the conduct of this study.&lt;br /&gt;&lt;br /&gt;NOTE: This differs from StudyObjective which describes what the study hopes to accomplish whereas the purposeStatement is the reason why the study is being conducted.
		</td>
	</tr>
</table></div>
</td>
			</tr>			<tr>
				<td width="40%" class="TableRow" valign="top"><i>public CD</i><br /><strong>&nbsp;&nbsp;designConfigurationCode</strong></td>
				<td width="60%" class="TableRow" valign="top"><i></i>Map:CTGOV=Observational Study Model<br>Map:CTGOV=Intervention Model<br>Map:CTGOV=Study Design<br>Map:WHO=Study Type Study Design Assignment<br><div class="ObjectDetailsNotes"><table>
	<tr>
		<td valign="top">
			<i>Notes: </i><span style="margin-left: .4cm;"> </span>
		</td>
		<td>
			Clinical trial pattern developed to compare treatment groups in a clinical trial.&lt;br /&gt;&lt;br /&gt;For example, Parallel Group Design, Crossover Design, Factorial&lt;br /&gt;Designs, Cohort, Case-control, Case-only, Case-crossover, Ecologic or Community Studies, Family-based, etc.&lt;br /&gt;&lt;br /&gt;NOTE: The configuration usually requires randomization to one or more&lt;br /&gt;treatment arms, each arm being allocated a different (or no) treatment.
		</td>
	</tr>
</table></div>
</td>
			</tr>			<tr>
				<td width="40%" class="TableRow" valign="top"><i>public ED</i><br /><strong>&nbsp;&nbsp;studySchematic</strong></td>
				<td width="60%" class="TableRow" valign="top"><i></i><div class="ObjectDetailsNotes"><table>
	<tr>
		<td valign="top">
			<i>Notes: </i><span style="margin-left: .4cm;"> </span>
		</td>
		<td>
			Schematic which outlines all study epochs, timing of randomization and duration of treatments.
		</td>
	</tr>
</table></div>
</td>
			</tr>			<tr>
				<td width="40%" class="TableRow" valign="top"><i>public CD</i><br /><strong>&nbsp;&nbsp;allocationCode</strong></td>
				<td width="60%" class="TableRow" valign="top"><i></i>Map:CTGOV=Study Design Allocation<br><div class="ObjectDetailsNotes"><table>
	<tr>
		<td valign="top">
			<i>Notes: </i><span style="margin-left: .4cm;"> </span>
		</td>
		<td>
			The method of assigning subjects to treatment or control groups.&lt;br /&gt;&lt;br /&gt;For example, n/a, randomized controlled trial, non-randomized trial.
		</td>
	</tr>
</table></div>
</td>
			</tr>			<tr>
				<td width="40%" class="TableRow" valign="top"><i>public CD</i><br /><strong>&nbsp;&nbsp;confidentialityCode</strong></td>
				<td width="60%" class="TableRow" valign="top"><i></i><div class="ObjectDetailsNotes"><table>
	<tr>
		<td valign="top">
			<i>Notes: </i><span style="margin-left: .4cm;"> </span>
		</td>
		<td>
			A code that controls the disclosure of information about a study protocol.&nbsp;<WBR> &lt;br /&gt;&lt;br /&gt;NOTE: This can be interpreted on a role-specific basis and therefore can facilitate role-based access control strategies. However it does not specify them.&nbsp;<WBR> Likewise it does not specify masking or related strategies but can be used to facilitate their implementation.&nbsp;<WBR>&nbsp;<WBR> 
		</td>
	</tr>
</table></div>
</td>
			</tr>			<tr>
				<td width="40%" class="TableRow" valign="top"><i>public ST</i><br /><strong>&nbsp;&nbsp;populationDescription</strong></td>
				<td width="60%" class="TableRow" valign="top"><i></i>Map:CTGOV=Study Population Description<br>Map:WHO=Health Condition(s) or Problem(s) Studied<br><div class="ObjectDetailsNotes"><table>
	<tr>
		<td valign="top">
			<i>Notes: </i><span style="margin-left: .4cm;"> </span>
		</td>
		<td>
			A text summary of subject characteristics, including inclusion and exclusion criteria and describes the population for which the study may be generalized. &lt;br /&gt;&lt;br /&gt;NOTE: This would include all subgroups as well.
		</td>
	</tr>
</table></div>
</td>
			</tr>			<tr>
				<td width="40%" class="TableRow" valign="top"><i>public CD</i><br /><strong>&nbsp;&nbsp;studySubjectTypeCode</strong></td>
				<td width="60%" class="TableRow" valign="top"><i></i><div class="ObjectDetailsNotes"><table>
	<tr>
		<td valign="top">
			<i>Notes: </i><span style="margin-left: .4cm;"> </span>
		</td>
		<td>
			The target entity of the study of investigation. &lt;br /&gt;&lt;br /&gt;For example, in a clinical trial, the subject type would be &quot;human&quot;. Other studies could involve animals (rats, mice). 
		</td>
	</tr>
</table></div>
</td>
			</tr>			<tr>
				<td width="40%" class="TableRow" valign="top"><i>public ST</i><br /><strong>&nbsp;&nbsp;plannedStudySubjectExperience</strong></td>
				<td width="60%" class="TableRow" valign="top"><i></i><div class="ObjectDetailsNotes"><table>
	<tr>
		<td valign="top">
			<i>Notes: </i><span style="margin-left: .4cm;"> </span>
		</td>
		<td>
			Sequence and duration of study epochs, including pre-randomization and post-treatment epochs, therapy withdrawal epochs, and single- and double-blind treatment epochs.&nbsp;<WBR> 
		</td>
	</tr>
</table></div>
</td>
			</tr>			<tr>
				<td width="40%" class="TableRow" valign="top"><i>public BL</i><br /><strong>&nbsp;&nbsp;acceptsHealthyVolunteersIndicator</strong></td>
				<td width="60%" class="TableRow" valign="top"><i></i>Map:CTGOV=Accepts Healthy Volunteers?<br><div class="ObjectDetailsNotes"><table>
	<tr>
		<td valign="top">
			<i>Notes: </i><span style="margin-left: .4cm;"> </span>
		</td>
		<td>
			Specifies whether persons who have not had the condition(s) being studied or otherwise related conditions or symptoms, as specified in the eligibility requirements, may participate in the study. 
		</td>
	</tr>
</table></div>
</td>
			</tr>			<tr>
				<td width="40%" class="TableRow" valign="top"><i>public IVL<INT></i><br /><strong>&nbsp;&nbsp;targetAccrualNumberRange</strong></td>
				<td width="60%" class="TableRow" valign="top"><i></i>Map:CTGOV=Enrollment<br>Map:WHO=Target Sample Size<br><div class="ObjectDetailsNotes"><table>
	<tr>
		<td valign="top">
			<i>Notes: </i><span style="margin-left: .4cm;"> </span>
		</td>
		<td>
			The number of subjects planned to be accrued to this study.&lt;br /&gt;&lt;br /&gt;NOTE: A target accrual number (always assumed to be a minimum target) would be targetAccrualRange.IVL&lt;INT&gt;.low, a maximum target accrual would be targetAccrualRange.IVL&lt;INT&gt;.high.
		</td>
	</tr>
</table></div>
</td>
			</tr>			<tr>
				<td width="40%" class="TableRow" valign="top"><i>public RTO<INT,PQ></i><br /><strong>&nbsp;&nbsp;periodicTargetAccrualNumber</strong></td>
				<td width="60%" class="TableRow" valign="top"><i></i><div class="ObjectDetailsNotes"><table>
	<tr>
		<td valign="top">
			<i>Notes: </i><span style="margin-left: .4cm;"> </span>
		</td>
		<td>
			The desired number of subjects accrued per a specified amount of time.&lt;br /&gt;&lt;br /&gt;For example, for monthly target accrual, a given study may have a target accrual of 100 per 1 month meaning the numerator of the ratio is the integer 100 and the denominator is a PQ where the value is 1 and the unit is month.
		</td>
	</tr>
</table></div>
</td>
			</tr>			<tr>
				<td width="40%" class="TableRow" valign="top"><i>public CD</i><br /><strong>&nbsp;&nbsp;accrualReportingMethodCode</strong></td>
				<td width="60%" class="TableRow" valign="top"><i></i><div class="ObjectDetailsNotes"><table>
	<tr>
		<td valign="top">
			<i>Notes: </i><span style="margin-left: .4cm;"> </span>
		</td>
		<td>
			A coded value to represent the specification or format on how subject accrual data should be reported back to the study sponsor.&lt;br /&gt;&lt;br /&gt;For example, complete, abbreviated.
		</td>
	</tr>
</table></div>
</td>
			</tr>			<tr>
				<td width="40%" class="TableRow" valign="top"><i>public CD</i><br /><strong>&nbsp;&nbsp;responsiblePartyCode</strong></td>
				<td width="60%" class="TableRow" valign="top"><i></i>Map:CTGOV=Responsible Party<br><div class="ObjectDetailsNotes"><table>
	<tr>
		<td valign="top">
			<i>Notes: </i><span style="margin-left: .4cm;"> </span>
		</td>
		<td>
			Indicates the type of entity who is legally responsible for the execution of the trial.&lt;br /&gt;&lt;br /&gt;For example, the PI or the sponsor.
		</td>
	</tr>
</table></div>
</td>
			</tr>			<tr>
				<td width="40%" class="TableRow" valign="top"><i>public BL</i><br /><strong>&nbsp;&nbsp;multiInstitutionIndicator</strong></td>
				<td width="60%" class="TableRow" valign="top"><i></i><div class="ObjectDetailsNotes"><table>
	<tr>
		<td valign="top">
			<i>Notes: </i><span style="margin-left: .4cm;"> </span>
		</td>
		<td>
			Specifies whether a protocol is being conducted at more than one site concurrently.&lt;br /&gt;&lt;br /&gt;NOTE: This could be conceived as derivable, but since it needs to be defined before study sites are associated with a study, it is needed here.
		</td>
	</tr>
</table></div>
</td>
			</tr>			<tr>
				<td width="40%" class="TableRow" valign="top"><i>public CD</i><br /><strong>&nbsp;&nbsp;participatingOrganizationTypeCode</strong></td>
				<td width="60%" class="TableRow" valign="top"><i></i><div class="ObjectDetailsNotes"><table>
	<tr>
		<td valign="top">
			<i>Notes: </i><span style="margin-left: .4cm;"> </span>
		</td>
		<td>
			Defines the type of organizational participation planned for this study.&lt;br /&gt;&lt;br /&gt;For example, Cancer Center, Clinical Center, Consortium, Group, Intergroup, Multi-Center, Network, or Single Institution.
		</td>
	</tr>
</table></div>
</td>
			</tr>			<tr>
				<td width="40%" class="TableRow" valign="top"><i>public SET<CD></i><br /><strong>&nbsp;&nbsp;participatingCountryCode</strong></td>
				<td width="60%" class="TableRow" valign="top"><i></i>Map:WHO=Countries of Recruitment<br><div class="ObjectDetailsNotes"><table>
	<tr>
		<td valign="top">
			<i>Notes: </i><span style="margin-left: .4cm;"> </span>
		</td>
		<td>
			The countries from which particpants will be, are intended to be, or have been recruited.
		</td>
	</tr>
</table></div>
</td>
			</tr>			<tr>
				<td width="40%" class="TableRow" valign="top"><i>public CD</i><br /><strong>&nbsp;&nbsp;AECodingSystem</strong></td>
				<td width="60%" class="TableRow" valign="top"><i></i><div class="ObjectDetailsNotes"><table>
	<tr>
		<td valign="top">
			<i>Notes: </i><span style="margin-left: .4cm;"> </span>
		</td>
		<td>
			Adverse event coding system used for recording AE for a trial.
		</td>
	</tr>
</table></div>
</td>
			</tr>
		</table>
</div>		<div class="ItemBody" id="AssociationsToTable">
			<table border="0" cellspacing="0" cellpadding="0" class="Table">
				<tr>
					<td width="20%" class="TableHeading">Element</td>
					<td width="25%" class="TableHeading">Source Role</td>
					<td width="25%" class="TableHeading">Target Role</td>
					<td width="30%" class="TableHeading">Details</td>
				</tr>
				<tr>
					<td width="20%" class="TableRow" valign="top">
						<a href="EA1606.htm">Epoch</a><br />
						Class &nbsp;
					</td>
					<td width="20%" class="TableRow" valign="top">
						<strong>Name:</strong> &nbsp;<br />
						&nbsp;
					</td>
					<td width="20%" class="TableRow" valign="top">
						<strong>Name:</strong> &nbsp;<br />
						&nbsp;	
					</td>
					<td width="30%" class="TableRow" valign="top"><div class="ObjectDetailsNotes">&lt;p&gt;This is a relationship between two acts. This relationship asserts that an epoch must be a division of one and only one study protocol. This relationship also asserts that a study protocol must be divided into one or more epochs.&lt;br/&gt;&lt;/p&gt;</div>
</td>
				</tr>
				<tr>
					<td width="20%" class="TableRow" valign="top">
						<a href="EA1781.htm">SoA</a><br />
						Class &nbsp;
					</td>
					<td width="20%" class="TableRow" valign="top">
						<strong>Name:</strong> &nbsp;<br />
						&nbsp;
					</td>
					<td width="20%" class="TableRow" valign="top">
						<strong>Name:</strong> &nbsp;<br />
						&nbsp;	
					</td>
					<td width="30%" class="TableRow" valign="top"><div class="ObjectDetailsNotes">&lt;p&gt;This is a relationship between two acts. This relationship asserts that a schedule of activities (SoA) groups activities for one and only one study protocol. This relationship also asserts that a study protocol has activities group by one and only one SoA.&lt;br/&gt;&lt;/p&gt;</div>
</td>
				</tr>

			</table>
		</div>
		<div class="ItemBody" id="AssociationsFromTable">
			<table border="0" cellspacing="0" cellpadding="0" class="Table">
				<tr>
					<td width="20%" class="TableHeading">Element</td>
					<td width="25%" class="TableHeading">Source Role</td>
					<td width="25%" class="TableHeading">Target Role</td>
					<td width="30%" class="TableHeading">Details</td>
				</tr>
				<tr>
					<td width="20%" class="TableRow" valign="top">
						<a href="EA1594.htm">Document</a><br />
						Class &nbsp;
					</td>
					<td width="20%" class="TableRow" valign="top">
						<strong>Name:</strong> &nbsp;<br />
						&nbsp;
					</td>
					<td width="20%" class="TableRow" valign="top">
						<strong>Name:</strong> &nbsp;<br />
						&nbsp;	
					</td>
					<td width="30%" class="TableRow" valign="top"><div class="ObjectDetailsNotes">&lt;p&gt;This is an aggregation relationship between two acts. This relationship asserts that a document groups zero to one study protocol. This relationship also asserts that a study protocol is grouped by one or more documents.&lt;br/&gt;&lt;/p&gt;</div>
</td>
				</tr>
				<tr>
					<td width="20%" class="TableRow" valign="top">
						<a href="EA1802.htm">StudySite</a><br />
						Class &nbsp;
					</td>
					<td width="20%" class="TableRow" valign="top">
						<strong>Name:</strong> &nbsp;<br />
						&nbsp;
					</td>
					<td width="20%" class="TableRow" valign="top">
						<strong>Name:</strong> &nbsp;<br />
						&nbsp;	
					</td>
					<td width="30%" class="TableRow" valign="top"><div class="ObjectDetailsNotes">&lt;p&gt;This is a relationship between a participation in an act. This relationship asserts that a study protocol is executed at one or more study sites. This relationship also asserts that a study site executes one and only one study protocol. Note: a StudySite may be related to either a HealthCareFacility or an Organization (serving as a StudySite but is not a HealthCareFacility).&lt;br/&gt;&lt;/p&gt;</div>
</td>
				</tr>
				<tr>
					<td width="20%" class="TableRow" valign="top">
						<a href="EA1790.htm">StudyContact</a><br />
						Class &nbsp;
					</td>
					<td width="20%" class="TableRow" valign="top">
						<strong>Name:</strong> &nbsp;<br />
						&nbsp;
					</td>
					<td width="20%" class="TableRow" valign="top">
						<strong>Name:</strong> &nbsp;<br />
						&nbsp;	
					</td>
					<td width="30%" class="TableRow" valign="top"><div class="ObjectDetailsNotes">&lt;p&gt;This is a relationship between an act and a pseudo-participation in the act.&#160; This relationship asserts that a study protocol must be conducted by one or more study contacts.&#160; This relationship also asserts that each study contact must participate in a single study protocol.&lt;br/&gt;&lt;/p&gt;</div>
</td>
				</tr>
				<tr>
					<td width="20%" class="TableRow" valign="top">
						<a href="EA1787.htm">StudyAuthor</a><br />
						Class &nbsp;
					</td>
					<td width="20%" class="TableRow" valign="top">
						<strong>Name:</strong> &nbsp;<br />
						&nbsp;
					</td>
					<td width="20%" class="TableRow" valign="top">
						<strong>Name:</strong> &nbsp;<br />
						&nbsp;	
					</td>
					<td width="30%" class="TableRow" valign="top"><div class="ObjectDetailsNotes">&lt;p&gt;This is a relationship between a participation in an act. This relationship asserts that a study protocol is authored by one or more study authors. This relationship also asserts that a study author develops one and only one study protocol. Note: a StudyAuthor can be played by a HealthCareProvider and ClinicalResearchStaff.&lt;br/&gt;&lt;/p&gt;</div>
</td>
				</tr>
				<tr>
					<td width="20%" class="TableRow" valign="top">
						<a href="EA1786.htm">StudyAgent</a><br />
						Class &nbsp;
					</td>
					<td width="20%" class="TableRow" valign="top">
						<strong>Name:</strong> &nbsp;<br />
						&nbsp;
					</td>
					<td width="20%" class="TableRow" valign="top">
						<strong>Name:</strong> &nbsp;<br />
						&nbsp;	
					</td>
					<td width="30%" class="TableRow" valign="top"><div class="ObjectDetailsNotes">&lt;p&gt;This is a relationship between a participation and an act. This relationship asserts that a study agent must be a research topic in one and only one study protocol. This relationship also asserts that a study protocol may be evaluating zero or more study agents.&lt;br/&gt;&lt;/p&gt;</div>
</td>
				</tr>
				<tr>
					<td width="20%" class="TableRow" valign="top">
						<a href="EA1794.htm">StudyObjective</a><br />
						Class &nbsp;
					</td>
					<td width="20%" class="TableRow" valign="top">
						<strong>Name:</strong> &nbsp;<br />
						&nbsp;
					</td>
					<td width="20%" class="TableRow" valign="top">
						<strong>Name:</strong> &nbsp;<br />
						&nbsp;	
					</td>
					<td width="30%" class="TableRow" valign="top"><div class="ObjectDetailsNotes">&lt;p&gt;This is a relationship between two acts. This relationship asserts that a study protocol contains one or more study objectives. This relationship also asserts that each study objective is contained in one and only study protocol.&lt;br/&gt;&lt;/p&gt;</div>
</td>
				</tr>
				<tr>
					<td width="20%" class="TableRow" valign="top">
						<a href="EA1574.htm">Arm</a><br />
						Class &nbsp;
					</td>
					<td width="20%" class="TableRow" valign="top">
						<strong>Name:</strong> &nbsp;<br />
						&nbsp;
					</td>
					<td width="20%" class="TableRow" valign="top">
						<strong>Name:</strong> &nbsp;<br />
						&nbsp;	
					</td>
					<td width="30%" class="TableRow" valign="top"><div class="ObjectDetailsNotes">&lt;p&gt;This is a relationship between two acts. This relationship asserts that an arm must be a division of one and only one study protocol. This relationship also asserts that a study protocol must be divided into one or more arms.&lt;br/&gt;&lt;/p&gt;</div>
</td>
				</tr>
				<tr>
					<td width="20%" class="TableRow" valign="top">
						<a href="EA1791.htm">StudyCoordinatingCenter</a><br />
						Class &nbsp;
					</td>
					<td width="20%" class="TableRow" valign="top">
						<strong>Name:</strong> &nbsp;<br />
						&nbsp;
					</td>
					<td width="20%" class="TableRow" valign="top">
						<strong>Name:</strong> &nbsp;<br />
						&nbsp;	
					</td>
					<td width="30%" class="TableRow" valign="top"><div class="ObjectDetailsNotes">&lt;p&gt;This is a relationship between an act and a participation in that act.&#160; This relationship asserts that a study coordinating center must manage key aspects of a single study protocol.&#160; This relationship also asserts that a study protocol must have key aspects managed by one or more study coordinating centers.&lt;br/&gt;&lt;/p&gt;</div>
</td>
				</tr>
				<tr>
					<td width="20%" class="TableRow" valign="top">
						<a href="EA1562.htm">Activity</a><br />
						Class &nbsp;
					</td>
					<td width="20%" class="TableRow" valign="top">
						<strong>Name:</strong> &nbsp;<br />
						&nbsp;
					</td>
					<td width="20%" class="TableRow" valign="top">
						<strong>Name:</strong> &nbsp;<br />
						&nbsp;	
					</td>
					<td width="30%" class="TableRow" valign="top"><div class="ObjectDetailsNotes">&lt;p&gt;This is an aggregation relationship between two acts. This relationship asserts that an activity is grouped by one and only one study protocol. This relationship also asserts that a study protocol groups one or more activities. &lt;br/&gt;&lt;/p&gt;</div>
</td>
				</tr>
				<tr>
					<td width="20%" class="TableRow" valign="top">
						<a href="EA1800.htm">StudyResourcing</a><br />
						Class &nbsp;
					</td>
					<td width="20%" class="TableRow" valign="top">
						<strong>Name:</strong> &nbsp;<br />
						&nbsp;
					</td>
					<td width="20%" class="TableRow" valign="top">
						<strong>Name:</strong> &nbsp;<br />
						&nbsp;	
					</td>
					<td width="30%" class="TableRow" valign="top"><div class="ObjectDetailsNotes">&lt;p&gt;This is a relationship between two acts.&#160; This relationship asserts that a study resourcing may be the resource for one or more study protocols.&#160; This relationship also asserts that a study protocol may be resourced by one or more study resourcings.&lt;br/&gt;&lt;/p&gt;</div>
</td>
				</tr>
				<tr>
					<td width="20%" class="TableRow" valign="top">
						<a href="EA1872.htm">StudyOverallStatus</a><br />
						Class &nbsp;
					</td>
					<td width="20%" class="TableRow" valign="top">
						<strong>Name:</strong> &nbsp;<br />
						&nbsp;
					</td>
					<td width="20%" class="TableRow" valign="top">
						<strong>Name:</strong> &nbsp;<br />
						&nbsp;	
					</td>
					<td width="30%" class="TableRow" valign="top"><div class="ObjectDetailsNotes">&lt;p&gt;This is a relationship between two acts. This relationship asserts that a study protocol has one or more study overall statuses. This relationship also asserts a study overall status describes one and only one study protocol.&lt;br/&gt;&lt;/p&gt;</div>
</td>
				</tr>
				<tr>
					<td width="20%" class="TableRow" valign="top">
						<a href="EA1873.htm">StudyRecruitmentStatus</a><br />
						Class &nbsp;
					</td>
					<td width="20%" class="TableRow" valign="top">
						<strong>Name:</strong> &nbsp;<br />
						&nbsp;
					</td>
					<td width="20%" class="TableRow" valign="top">
						<strong>Name:</strong> &nbsp;<br />
						&nbsp;	
					</td>
					<td width="30%" class="TableRow" valign="top"><div class="ObjectDetailsNotes">&lt;p&gt;This is a relationship between two activities. This relationship asserts that a study protocol may have zero or more study recruitment statuses. This relationship also asserts that a study recruitment status describes one and only one study protocol.&lt;br/&gt;&lt;/p&gt;</div>
</td>
				</tr>
				<tr>
					<td width="20%" class="TableRow" valign="top">
						<a href="EA1797.htm">StudyReference</a><br />
						Class &nbsp;
					</td>
					<td width="20%" class="TableRow" valign="top">
						<strong>Name:</strong> &nbsp;<br />
						&nbsp;
					</td>
					<td width="20%" class="TableRow" valign="top">
						<strong>Name:</strong> &nbsp;<br />
						&nbsp;	
					</td>
					<td width="30%" class="TableRow" valign="top"><div class="ObjectDetailsNotes">&lt;p&gt;This is a relationship between two acts. This relationship asserts that a study protocol is described by zero or more study references. This relationship also asserts that a study reference describes one or more study protocols.&lt;br/&gt;&lt;/p&gt;</div>
</td>
				</tr>
				<tr>
					<td width="20%" class="TableRow" valign="top">
						<a href="EA1793.htm">StudyLegalSponsor</a><br />
						Class &nbsp;
					</td>
					<td width="20%" class="TableRow" valign="top">
						<strong>Name:</strong> &nbsp;<br />
						&nbsp;
					</td>
					<td width="20%" class="TableRow" valign="top">
						<strong>Name:</strong> &nbsp;<br />
						&nbsp;	
					</td>
					<td width="30%" class="TableRow" valign="top"><div class="ObjectDetailsNotes">&lt;p&gt;This is a relationship between an act and a participation in that act.&#160; This relationship asserts that a study protocol may be the responsibility of a single study legal sponsor.&#160; This relationship also asserts that a study legal sponsor must be responsible for a single protocol.&lt;br/&gt;&lt;/p&gt;</div>
</td>
				</tr>
				<tr>
					<td width="20%" class="TableRow" valign="top">
						<a href="EA1795.htm">StudyOversightAuthority</a><br />
						Class &nbsp;
					</td>
					<td width="20%" class="TableRow" valign="top">
						<strong>Name:</strong> &nbsp;<br />
						&nbsp;
					</td>
					<td width="20%" class="TableRow" valign="top">
						<strong>Name:</strong> &nbsp;<br />
						&nbsp;	
					</td>
					<td width="30%" class="TableRow" valign="top"><div class="ObjectDetailsNotes">&lt;p&gt;This is a relationship between an act and a participation in the act.&#160; This relationship asserts that a study protocol may be overseen by one or more study oversight authorities.&#160; This relationship also asserts that a study oversight authority must oversee a single study protocol.&lt;br/&gt;&lt;/p&gt;</div>
</td>
				</tr>
				<tr>
					<td width="20%" class="TableRow" valign="top">
						<a href="EA1780.htm">ServiceProvider</a><br />
						Class &nbsp;
					</td>
					<td width="20%" class="TableRow" valign="top">
						<strong>Name:</strong> &nbsp;<br />
						&nbsp;
					</td>
					<td width="20%" class="TableRow" valign="top">
						<strong>Name:</strong> &nbsp;<br />
						&nbsp;	
					</td>
					<td width="30%" class="TableRow" valign="top"><div class="ObjectDetailsNotes">&lt;p&gt;This relationship is an implicit participation in an act by an entity in a role.&#160; This relationship asserts that a service provider may provide services for one or more study protocols.&#160; This relationship also asserts that a study protocol may by serviced by one or more service providers.&lt;br/&gt;&lt;/p&gt;</div>
</td>
				</tr>

			</table>
		</div>
		<div class="ItemBody" id="LinksTable">
			<table align="center" border="0" cellspacing="0" cellpadding="0" class="Table">
				<tr>
					<td width="30%" class="TableHeading">Object</td>
					<td width="15%" class="TableHeading">Type</td>
					<td width="15%" class="TableHeading">Connection</td>
					<td width="40%" class="TableHeading">Notes</td>
				</tr>
				<tr>
					<td width="30%" class="TableRow" valign="top"><a href="EA1594.htm">Document</a></td>
					<td width="15%" class="TableRow" valign="top">Class</td>
					<td width="15%" class="TableRow" valign="top">Strong</td>
					<td width="40%" class="TableRow" valign="top">This is an aggregation relationship between two acts. This relationship asserts that a document groups zero to one study protocol. This relationship also asserts that a study protocol is grouped by one or more documents.</td>
				</tr>
				<tr>
					<td width="30%" class="TableRow" valign="top"><a href="EA1594.htm">Document</a></td>
					<td width="15%" class="TableRow" valign="top">Class</td>
					<td width="15%" class="TableRow" valign="top">Generalization</td>
					<td width="40%" class="TableRow" valign="top">&nbsp;</td>
				</tr>
				<tr>
					<td width="30%" class="TableRow" valign="top"><a href="EA1562.htm">Activity</a></td>
					<td width="15%" class="TableRow" valign="top">Class</td>
					<td width="15%" class="TableRow" valign="top">Strong</td>
					<td width="40%" class="TableRow" valign="top">This is an aggregation relationship between two acts. This relationship asserts that an activity is grouped by one and only one study protocol. This relationship also asserts that a study protocol groups one or more activities. </td>
				</tr>
				<tr>
					<td width="30%" class="TableRow" valign="top"><a href="EA1620.htm">InterventionalStudyProtocol</a></td>
					<td width="15%" class="TableRow" valign="top">Class</td>
					<td width="15%" class="TableRow" valign="top">Generalization</td>
					<td width="40%" class="TableRow" valign="top">&nbsp;</td>
				</tr>
				<tr>
					<td width="30%" class="TableRow" valign="top"><a href="EA1699.htm">ObservationalStudyProtocol</a></td>
					<td width="15%" class="TableRow" valign="top">Class</td>
					<td width="15%" class="TableRow" valign="top">Generalization</td>
					<td width="40%" class="TableRow" valign="top">&nbsp;</td>
				</tr>
				<tr>
					<td width="30%" class="TableRow" valign="top"><a href="EA1608.htm">ExpandedAccessStudyProtocol</a></td>
					<td width="15%" class="TableRow" valign="top">Class</td>
					<td width="15%" class="TableRow" valign="top">Generalization</td>
					<td width="40%" class="TableRow" valign="top">&nbsp;</td>
				</tr>

			</table>
		</div>
	</div>
<div class="pageFooter"></div>
 
</body>
</html>